UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000013169
Receipt No. R000015356
Scientific Title Phase I/II study of bortezomib plus Lenalidomide and dexamethasone (Once weekly VRd-21) for relapsed and/or refractory multiple myeloma (Once weekly VRd-21, I/II VRD for MM)
Date of disclosure of the study information 2014/02/15
Last modified on 2016/02/22 10:57:55

No. Disposal Last modified on Item of update
1 Insert 2014/02/15 00:24:09
2 Update 2014/09/23 01:14:51 UMIN ID1
3 Update 2014/09/23 01:20:49 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
4 Update 2014/09/23 01:24:46

5 Update 2015/02/23 09:21:10 Recruitment status
6 Update 2015/09/19 16:49:48 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results
7 Update 2015/09/19 16:58:18 Control
8 Update 2016/02/22 10:57:55 Recruitment status
Publication of results

Contact us.